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                                          ABSTRACT 
 
TITLE: A COMPARATIVE STUDY BETWEEN SINGLE DOSE   
INTRALESIONAL AUTOLOGOUS BLOOD AND CORTICOSTEROID INJECTION IN 
CHRONIC PLANTAR FASCIITIS-A SHORT TERM FOLLOWUP             
STUDY 
 
AIM OF THE STUDY: 
                    
            1. To compare the effectiveness of single dose intra-lesional injection 
of autologous   blood and corticosteroid in chronic plantar fasciitis.  
            
            2. To note the incidence of heel spur in chronic plantar fasciitis and 
to analyze the outcome of intra-lesional injections in patients with heel spur. 
 
MATERIALS AND METHODS: 
             This study was done in Coimbatore medical college hospital during 
the period of June-October 2011 in the dept. of orthopaedics. 50 patients 
entered the study with 25 patients in each group. The patients were selected 
according to our inclusion and exclusion criteria and diagnosis made on 
clinical examination alone. The pain status was noted on the visual analog 
scale and the activity level noted based on the Nirschl stage. The patients 
were followed at 2, 4 and 12 weeks post-injection and the pain and activity 
level noted. The final outcome was based on our scoring system based on 
the pain status and the activity level at the end of 12 weeks duration and 
graded into 4 categories as excellent, good, and acceptable and poor. X-ray 
ankles of the patients were also taken to calculate the incidence of heel spur 
in chronic plantar fasciitis. The final outcome in the group with heel spur 
was also analyzed separately.  
 
RESULTS/CONCLUSION: 
           We concluded that in chronic plantar fasciitis: 
 
           1. Local intra-lesional steroid injection gives better pain relief and 
faster return to activities of daily living compared to autologous blood 
injections. 
           2. Autologous blood injections also provide pain relief, although not 
comparable to steroids in the speed of recovery, but produces sustained 
effects and are easily available with no potential risk. 
           3. Heel spurs are present in 54 % of patients with chronic plantar 
fasciitis, compared to its 10% presence in general population. 
           4. The final outcome in patients with heel spurs was nearly 
comparable to those without heel spurs. 
 
 
KEYWORDS: 
1. Chronic plantar fasciitis 
2. Intra-lesional injection 
3. Autologous blood 
4. Corticosteroid 
5. Heel spur 
6. Visual analog scale 
7. Nirschl stage 
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INTRODUCTION: 
                      Plantar fascia by repetitive overuse or overstretching gets 
inflamed resulting in a condition called as plantar fasciitis1. In chronic plantar 
fasciitis, inflammation and degeneration go hand in hand. This is one of the 
commonest chronic tendinopathies   affecting   humans. It typically affects both 
men and women in the age group of 40-70 yrs predominantly in women1. It 
occurs in 10% of the general population and is bilateral in 33% of cases. 
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AIM: 
            1. To compare the effectiveness of single dose intra-lesional injection of 
autologous   blood and corticosteroid in chronic plantar fasciitis.  
            2. To note the incidence of heel spur in chronic plantar fasciitis and to 
analyze the outcome of intra-lesional injections in patients with heel spur. 
 
 
 
 
 
 
 
 
 
 
 
3 
 
ANATOMY OF THE PLANTAR FASCIA/APONEUROSIS: 
The plantar fascia consists mainly of longitudinally arranged white colored    
fibres running from the calcaneum to the toes. 
ATTACHMENTS: 
Proximal: Attached to the medial tubercle of the calcaneum. 
Distal: The fascia fans out into 5 slips against the metatarsophalangeal joints 
and gets attached to the base of the proximal phalanges of the respective toes. 
The main parts are: 
1. Central, 
2. Medial, and 
3. Lateral bands. 
          The central band is thicker and narrow proximally than is distally. It gets 
attached to the calcaneal tuberosity at its medial process. Distally it divides into 
5 processes near the heads of the metatarsals, one for each toe. Each band 
divides into a superficial and a deep stratum against the metatarsophalangeal 
joint of the respective toes. The superficial stratum gets attached to the 
transverse sulcus of the skin. The deep stratum divides into two slips each 
engulfing the sides of the flexor tendons. They finally get attached to the 
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sheaths of their respective tendons and to the transverse metatarsal ligament 
and forms a series of arches through which the flexor tendons pass to the toes. 
The central portion is continuous with that of the lateral and medial ones. Two 
vertical intermuscular septae arise at the site where the medial and lateral bands 
join with the central one. These septae separate the three groups of plantar 
muscles (central, medial and lateral). 
        The medial portion is continuous with the central portion laterally and 
medially, it is continuous with the dorsal fascia. It is relatively thin compared 
with the other two portions and is attached posteriorly to the laciniate ligament. 
        The lateral portion is continuous with the central portion medially and 
laterally, it is continuous with the dorsal fascia. It is thicker posteriorly and 
thinner anteriorly. 
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BIOMECHANICS OF THE PLANTAR FASCIA: 
         The plantar fascia contributes to the maintenance of the longitudinal arch 
of the foot. It undergoes tension when the foot normally bears weight, thereby 
maintaining the arch. According to a biomechanical study model, the plantar 
fascia bears 14% of the load of the foot2. In another cadaveric study, the plantar 
fascia failed only at loads as high as 1189 newtons2.This failure most often 
occurred at the proximal attachment site at the calcaneum. This is consistent 
with the site involved in chronic plantar fasciitis, which is located at the 
calcaneum. Complete surgical release led to a decrease in the stiffness of the 
longitudinal arch of the foot. 
        The plantar fascia plays a vital role in the dynamic function during normal 
gait. It elongates to an extent of 9-12% between mid stance and toe off phase of 
gait, thereby to aid in propulsive movement. During the propulsive phase, the 
toes are dorsiflexed, thereby resulting in tension of the fascia which results in 
elevation of the longitudinal arch of the foot. This is likened to the windlass 
mechanism2. 
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WINDLASS MECHANISM: 
        A windlass is a device used to move heavy weights. It was used in boats 
and ships to raise anchors. The plantar fascia is compared to the windlass 
mechanism. During normal weight bearing, the body weight is transmitted to 
the ground through the tibia and the talus. The ground reaction force tends to 
pass upwards from the calcaneus and the metatarsals. Both the above forces 
tend to collapse the medial longitudinal arch of the foot. The plantar fascia   
gets taut during dorsiflexion and prevents collapse of the medial longitudinal 
arch, thereby acting as a windlass or a tie-rod. 
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PATHOLOGY OF CHRONIC PLANTAR FASCIITIS: 
         Repetitive tensile overload of the plantar fascia at its attachment to the 
calcaneum leads to pathological changes similar to that seen in inflammation 
and degeneration. The pathology passes through a cascade of events including 
inflammation and degeneration3. There may be an associated heel cord 
contracture. But the real cause for the pain in chronic plantar fasciitis seems to 
be unclear till date3. According to some authors, the primary pathology in this 
condition is degeneration of the plantar fascia rather than true inflammation 
seen in acute conditions4. 
        The plantar fascia gets attached to a relatively small area on the calcaneal 
tuberosity proximally. Distally it attaches to the base of the proximal phalanges 
of the toes which fans over a greater area. This arrangement exerts a greater 
pulling force at its proximal attachment site. Hence the maximum site of pain is 
at the calcaneum. This force creates a pull on the periosteum of the calcaneum. 
Periosteum is a pain sensitive part richly innervated by nerve fibres explaining 
the pain of plantar fasciitis. There also exists fibrous continuity of the plantar 
fascia into the bony matrix of the calcaneum thereby stimulating the 
overgrowth of new bone and resulting in the formation of a heel spur.  The 
pathological changes are similar to that for other chronic tendinopathies and 
include inflammation, collagen degeneration, increase in ground substance and 
vascularity4. 
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HEEL SPUR:  
        Plantar fasciitis and heel spur are considered to be the same by many. But 
in reality this is not true1, 5. Plantar fasciitis is a pathological diagnosis, whereas 
heel spur is a radiological finding. A heel spur may be present without any foot 
symptoms and a painful heel may not have a heel spur present always5. Heel 
spurs occur in 15% of population5. The presence of heel spur may only suggest 
the diagnosis of plantar fasciitis, but are not confirmatory evidence. 
Heel spurs can occur in 2 distinct locations: 
1. Back of the heel in chronic Achilles tendinitis, 
2. under the heel in chronic plantar fasciitis. 
Development of heel spurs: 
        Heel spurs develop as a result of bony outgrowth at the site of attachment 
of the plantar fascia to the calcaneum6. The stress is maximal in the plantar 
fascia at its calcaneal attachment and hence it’s repetitive over pull results in 
bony overgrowth. 
       The below picture shows a heel spur under the heel as can be seen in 
chronic plantar fasciitis (the red arrow points towards the heel spur). 
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                                            HEEL SPUR 
 
 
 
     Heel spurs usually occur in middle aged people and in athletes, it can occur 
at an even early age. This is due to the repeated stress on their heels. Abnormal 
gait may also lead to its development. In persons with abnormal gait pattern, 
the foot strikes the ground regularly in an unusual manner that leads to repeated 
stress and stretching of the plantar fascia that result in bony overgrowth   
leading to the development of a heel spur6. 
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CAUSES OF CHRONIC PLANTAR FASCIITIS: 
        The most common cause is the presence of very tight calf muscles which 
results in excessive over pronation of the foot. This leads to overstretching of 
the plantar fascia resulting in inflammation/degeneration of the fascia. 
Similarly over supination can also lead to altered foot biomechanics 
predisposing to its development. Other causes may be very high or very low 
arched feet and regular use of footwear with poor arch support. 
RISK FACTORS1: 
Foot abnormalities including: 
1. Very high arched feet, 
2. Very low arched feet, 
3. Flatfeet, 
4. Rigid feet, 
Other risk factors are: 
5. Increased age, 
6. Family tendency, 
7. Poor/altered gait pattern, 
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8. Poor arch support in footwear, 
9. Tight calf muscles and 
10. Excess body weight. 
  
CLINICAL FEATURES: 
-Heel pain. 
-Tenderness under the heel may be present. 
-Heel pain is usually maximal in the early morning as the person gets up from     
bed as the fascia gets tight overnight and gets lessened as the foot gets warmed 
up. Later on, the pain may persist throughout the day7. 
 
DIAGNOSIS: 
Clinical examination alone forms the basis of the diagnosis8, 9. 
-Mild swelling,  
-Redness +/-, 
-Tenderness under the heel. 
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INVESTIGATIONS: 
-X-rays may be done to rule out other conditions, but are not absolutely 
necessary. 
-USG-May show thickened plantar fascia, but are not diagnostic. 
-MRI scan is done only if pain persists despite all treatment regimes and only 
to rule out other causes of heel pain. 
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DIFFERENTIAL DIAGNOSIS OF HEEL PAIN7: 
1. Neurologic like entrapment syndromes, 
2. Calcaneal stress fracture, 
3. Skeletal causes like Paget’s disease, 
4. Tumours, 
5. Calcaneal apophysitis, 
6. Fat pad syndrome, 
7. Bursitis, 
8. Tendinitis, etc. 
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TREATMENT OF CHRONIC PLANTAR FASCIITIS: 
         There are several treatment options available for chronic plantar fasciitis. 
The initial treatment is usually with conservative means including rest, ice 
packs, NSAID’S and footwear modifications7, 10, 11. 
          Most of the patients get relieved of their pain with this treatment regime. 
Patients with pain not responsive to the above treatment protocol are subjected 
to more aggressive modalities. The available treatment options can be 
classified as: 
1. Conservative and 
2. Invasive. 
CONSERVATIVE TREATMENT: 
REST/IMMOBILIZATION: 
         Rest is usually the initial recommendation for most patients. But 
rest/immobilization can be continued only for short periods and is beneficial 
only in acute cases where inflammation is supposed to be the primary 
pathology. But in chronic cases where degeneration also exists, rest has got a 
very limited role, but still can be tried. 
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ICE THERAPY: 
         Ice packing is a form of treatment where ice packs are applied locally to 
the site of inflammation. This helps to reduce the pain associated with 
inflammation.  
NIGHT SPLINTS: 
         Night splints are tried with the hope of maintaining the limb in a neutral 
position. One major risk factor for chronic plantar fasciitis is the presence of 
very tight calf muscles. This treatment aims to solve it by splinting and 
maintaining the limb in a neutral position, thereby the plantar fascia is stretched 
and elongated and hence healing may occur in that position. 
MASSAGE: 
        Friction massage is by which mechanical breakdown of tissue occurs. But 
long term reports are not available. 
ORTHOTICS: 
       Heel pads and arch supports are the common orthotics advised to patients 
with chronic plantar fasciitis. Heel pads are made up of silicone, rubber or gel 
foam. They absorb the shock of uneven weight bearing thereby reducing the 
stress on the plantar fascia. Arch supports are given to the shoes to maintain the 
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longitudinal arch of the foot in patients with very high or very low arched and 
flatfeet12, 13. 
STRETCHING: 
       Stretching of the plantar fascia can be useful for chronic cases. 
NSAID’S: 
       NSAID’S are non steroidal anti-inflammatory drugs that acts by inhibiting 
the enzyme cyclooxygenase which catalyses the formation of prostaglandins. 
Prostaglandins are primary mediators of inflammation. By inhibiting the 
formation of prostaglandins, inflammation is reduced. Hence its use in acute 
cases seems to be logical. Also long term intake of analgesics is not advisable 
as it results in gastrointestinal bleeding, renal and liver damage14. 
ULTRASOUND AND PHONOPHORESIS: 
Mechanism of action: 
       High frequency ultrasound wave when delivered to a targeted tissue breaks 
them down by heating the tissues. In chronic plantar fasciitis, this has a role by 
breaking down the involved fascial tissues. 
      Phonophoresis is a technique in which the target area is subjected to 
ultrasound waves after applying a cream of corticosteroid which drives the 
ultrasound waves deep into the tissues thereby breaking down the heated tissue. 
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EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY (ESWL): 
       This is a relatively newer treatment method. It is also known as 
orthotripsy.Basically, there are two types of orthotripsy according to the waves 
that are generated. Studies show only poor results with its usage15, 16. 
High energy waves:  
Advantages: 
1. More effective than low energy waves, 
2. May need lower sittings. 
Disadvantages: 
1. Require costly equipments, 
2. May not be available at all centers, 
3. Very painful during exposure, 
4. Patient needs to be under anesthesia/sedation to tolerate pain. 
Low energy waves: 
Advantages: 
1. No need for anesthesia, 
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2. Less expensive equipments, 
3. Less painful during exposure. 
Disadvantages: 
1. May need multiple sittings, 
2. Less effective compared to high energy waves. 
 
LASER THERAPY: 
             Laser waves are delivered to the plantar fascia through one of the 
following 3 modes as given below: 
1. LLLT-Low level laser therapy, 
2. LED-Light emitting diodes, 
3. SLD-Super luminous diodes. 
ELECTRICAL STIMULATION/IONTOPHORESIS: 
          This works on the same principle as ultrasound waves do. A combination 
of applying a steroid cream over the affected area, followed by electrical 
stimulation is known as iontophoresis.Limited reports are only available to 
support its use. 
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INVASIVE: 
PROLOTHERAPY/SCLEROTHERAPY: 
Mechanism of action: 
       An irritant substance injected into an affected area stimulates the 
inflammatory cascade and allows the tissues to heal by scarring down the area. 
Its role in chronic plantar fasciitis is still at an investigational stage. 
LOCAL INJECTIONS: 
       Several drugs/substances can be injected locally into the affected plantar 
tissues to bring about healing/resolution of the condition. Local/ Intra-lesional 
injections can be made accurate by localizing the affected tissue by ultrasound 
imaging17. Several studies indicate the relative advantage/disadvantage of one 
substance over the other18, 19, and 20. Some of the commonly injected substances 
are given below: 
1. Corticosteroids, 
2. Botulinum toxin, 
3. Autologous blood, 
4. Platelet rich plasma. 
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CORTICOSTEROID INJECTIONS: 
Mechanism of action: 
      Corticosteroids exerts its anti-inflammatory effect by lipocortin-1 
synthesis.Lipocortin-1 inhibits phospholipase A2 thereby preventing the 
formation of prostaglandins and leukotreines which are primary mediators of 
inflammation. It also inhibits various inflammatory events like white blood cell 
migration, chemo taxis, phagocytosis, etc. 
Role in chronic plantar fasciitis: 
       The anti-inflammatory role of corticosteroids may not play a part here 
except in acute conditions. But the beneficial effect of corticosteroids in this 
condition seems to exist since long time. Corticosteroids are known to inhibit 
proliferation of fibroblasts and to decrease the synthesis of ground substances21, 
22. The beneficial effect of steroid injection may be due to the above action 
rather than its anti-inflammatory role. 
Mode of injection: 
      Injection of steroid is made after palpating the area of maximum 
tenderness. It is usually injected in combination with a local anesthetic agent to 
tolerate the immediate post-injection pain. 
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Advantages: 
1. Very effective23, 
2. Even single injection may bring about resolution of the condition24, 
3. cost-effective, 
4. Do not need expensive equipments. 
Disadvantages: 
1. Invasive procedure, 
2. Cannot be done in patients with uncontrolled diabetes/hypertension, 
3. Side effects are common which includes plantar fascial rupture, fat pad 
necrosis, etc25, 26. 
Commonly used preparations: 
2 types of corticosteroids are used for treatment of chronic inflammatory 
musculoskeletal conditions. 
1. Methylprednisolone acetate (moderately insoluble, long acting) and 
2. Fluorinated hydrocortisone i.e. Betamethasone, Dexamethasone, etc (highly 
soluble, short acting). 
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Methylprednisolone acetate has 5 times the glucocorticoid action of 
prednisolone and is 1.25 to 1.5 times stronger than prednisolone. 
Betamethasone is 8 to 10 times potent than prednisolone27. 
 
BOTULINUM TOXIN INJECTIONS: 
        Botulinum toxin injections have been used for refractory plantar fasciitis 
in previous days. It can be injected into the plantar fascia at the site of 
tenderness or if it is due to tight calf muscles, injection is done into the muscle 
substance. Studies indicate some advantage of this injection compared to 
placebo28. 
Mechanism of action: 
        In the fascia, it relieves the pain by destroying the pain sensitive nerve 
fibres.If the injection is made into the tight calf muscles, it acts by causing 
muscle relaxation and decreasing muscle volume. Actions common to both 
these sites include decreasing central sensitization, decreasing sympathetic 
activity and reducing the accumulation of pain mediators like substance-p and 
glutamate. 
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AUTOLOGOUS BLOOD INJECTIONS: 
       This is injection of the affected tissue with the patient’s own blood in small 
quantities. This is a relatively newer technique and has become an alternative 
to corticosteroid injections in recent times. Autologous blood injection was 
initially done by Edwards and Calandruccio in 2004 for tennis elbow with good 
outcome29. It was gradually extended for other tendinopathies and chronic 
inflammatory conditions. 
Mechanism of action: 
      Autologous blood when injected into an area of inflammation/degeneration 
tends to provide cellular/ humoral mediators and growth factors. These growth 
factors tend to recruit stem cells and results in collagen synthesis and repair of 
the degenerated tissues resulting in healing30. 
Mode of injection: 
      Around 2 ml of venous blood of the patient is drawn and mixed with 1 ml 
of a local anesthetic and injected into the area of maximum tenderness.  
Advantages: 
1. No chance of reaction as the patient’s own blood is injected, 
2. Cost-effective, 
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3. No need for expensive equipment. 
Disadvantages: 
1. May take a long time to act, 
2. Patient may not accept it. 
PLATELET RICH PLASMA INJECTIONS: 
Mechanism of action: 
      Similar to that of autologous blood, but here the same effect is brought 
about by centrifuged platelet rich plasma rather than the administration of 
whole blood. 
Advantages: 
1. No reaction to injected substance. 
Disadvantages: 
1. Needs centrifugation apparatus, 
2. Need more quantities of blood to be drawn, 
3. May need multiple injections, 
4. Patient may need to restrict activities for few weeks. 
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COMPLICATIONS OF LOCAL INTRALESIONAL INJECTIONS: 
1. Infection, 
2. Cellulitis, 
3. Nerve damage, 
4. Plantar fascial rupture, 
5. Heel pad necrosis and 
6. Persistence/increase in pain.            
Needle/ Percutaneous Fasciotomy: 
Indications: 
1. Plantar fasciitis not responding to conservative management for 6-9 months. 
2. Patients not willing for operative procedures. 
Surgical principle: 
1. The local trauma and bleeding produced by the puncturing of the fascia may 
produce a physiological response similar to that seen with autologous blood 
injections. 
2. May mechanically breakdown the calcifications in the fascia. 
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Technique: 
      A wide bore needle is introduced into the plantar fascia either blindly or 
under ultrasound guidance and multiple punctures are made in single or 
multiple sessions. This may also be combined with local anesthetic infiltration 
and is referred to as peppering technique of local anesthesia. 
 
SURGERY: 
      Surgery for chronic plantar fasciitis is only for recalcitrant cases for which 
conservative treatment have been exhausted for a period of at least 6-9 months. 
Success rate ranges from 70 to 90%31, 32. The various surgical options are: 
1. Plantar fascial release (complete/partial), 
2. Excision of the heel spur, 
3. Nerve decompression. 
The surgical technique may be: 
1. Open, 
2. Endoscopic. 
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Complete plantar fascial release: 
        It involves release of the entire plantar fascia and has its own demerits and 
hence has almost been withdrawn. If at all release of the plantar fascia is to be 
considered, only a   release of less than 40% is to be done to prevent collapse of 
the arch of foot. 
Disadvantages/complications: 
1. Collapse of the longitudinal foot arch leading to altered gait and mid tarsal 
pain due to altered biomechanics, 
2. Infection, 
3. Calcaneal fracture, 
4. Posterior tibial nerve injury, etc. 
 
RECENT ADVANCE: 
Radiofrequency microtenotomy: 
        A probe is introduced into the plantar fascia and high frequency radio 
wave is introduced into it which burns the affected tissue. It also has its 
deleterious effect on pain transmitting sensory nerve fibres thereby relieving 
the pain. This technique is referred to as the coblation therapy33. 
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TREATMENT OF HEEL SPURS: 
      Heel spurs are usually satisfactorily treated by conservative means like 
NSAID’S, orthotics, heel stretching, and etc6. In cases with heel spurs that are 
not responsive to the above treatment methods, excision of the spur may be 
considered. 
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LITERATURE REVIEW: 
-Chronic plantar fasciitis is known to be a chronic inflammatory foot condition 
since time immemorial. 
-Lemont et al in 2003 studied 50 cases labeled as chronic plantar fasciitis and 
evidenced very little inflammatory cells and hence said  this condition be better 
called as plantar fasciosis34. 
- Barnett, in 2004 pointed out that inflammatory cells are least evident in this 
condition and called the term plantar fasciitis to be a misnomer. He considered 
the pathology to be a degeneration of the plantar fascia34. 
-Khan et al also committed that the pathology in this condition is collagen 
degeneration as with other tendinopathies. 
-Treatment for plantar fasciitis is conservative at the beginning, consisting of 
non-steroidal anti-inflammatory drugs (NSAID’S), plantar fascia night splints, 
well-cushioned shoes, heel pads or heel cups, orthotics, and physical therapy. 
Stretching of the plantar fascia and heel cord is often beneficial7. 
-In changi general hospital, Singapore, study was conducted to determine the 
rear foot pressures in cases with heel spurs. It reported uneven pressure 
distributions in such cases and rear foot pressure was reduced with the use of 
customized orthotics12. 
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-According to Dr. Weil, Cryo ablation has been in use since 2003 with over 
5000 cases of chronic plantar fasciitis treated with this all over United States. 
The overall success rate ranged between 80-93 percent33. 
-Haake, Buchbinder reported poor results with extracorporeal shock wave 
lithotripsy, whereas Ogden reported good results15, 16, and 20. 
-Babcock et al. studied the effectiveness of botulinum toxin injections and 
produced good results in terms of pain relief28. 
- Crawford and Gudeman concluded that intra lesional steroid injections are 
beneficial in acute cases and in short term therapy. But the incidence of 
complications related to steroids were high and included plantar fascial rupture, 
calcaneal fracture and calcaneal osteomyelitis23. 
-Calandruccio and Edwards in 2004 tried intra lesional autologous blood 
injections for recalcitrant tennis elbow and produced good results29. 
-Barrett et al extended the application of autologous blood to plantar fasciitis 
and reported similar results. He also used autologous platelet concentrate for 
the same condition and obtained similar results. This technique of injection of 
platelet concentrate into the lesion of plantar fasciitis was attributed by him as 
plantar fasciorraphy34. 
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-Dr.Martin Robert presented his results in AMSSM meeting with the use of 
intra lesional autologous blood that it is a safe and simple alternative technique 
that gives results better than other standard treatments in recalcitrant cases. 
- Lee TG and Ahmad TS conducted a comparative study between autologous 
blood and corticosteroid injection in chronic plantar fasciitis and reported that 
autologous blood was found to be effective in lowering the pain associated with 
the condition, but corticosteroids were much better in speed and the overall 
outcome of recovery19. 
-Kiter et al in 2006 published in JAPMA that the results of intra lesional 
injection of corticosteroids, autologous blood and peppering technique are 
equally comparable35. 
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DRUGS USED: 
1. 2 ml of autologous blood with 1 ml of 2% lignocaine 
2. 2 ml of betamethasone sodium phosphate (8mg) with 1 ml of 2% lignocaine. 
 Betamethasone sodium phosphate was used since it had a combination of 
features like high potency and high solubility3. Usage of insoluble steroids in 
soft tissue disorders is not recommended. Also it is cost-effective compared to 
other steroids. 
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AUTOLOGOUS BLOOD:  
 
 
 
BETAMETHASONE SODIUM PHOSPHATE: 
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MAIN OUTCOME MEASUREMENTS: 
              The main outcomes measured were subjective based on the visual 
analog scale and the nirschl stages done pre-injection, 2, 4 and 12 weeks post-
injection. Final outcome was measured based on the pain and activity level at 3 
months. Incidence of heel spurs in chronic plantar fasciitis and the outcome of 
our injections in patients with heel spurs were analyzed. 
NIRSCHL STAGING: 
According to this, pain and activity level are categorized in 7 stages: 
0. No pain 
1. Mild pain with exercise which resolves within 24 hours. 
2. Pain after exercise which exceeds 48 hours. 
3. Pain with exercise, but allows normal activity. 
4. Pain with exercise which interferes with normal activities. 
5. Pain with heavy activities of daily living, but able to do light activity. 
6. Pain with light activities of daily living and intermittent rest pain. 
7. Constant pain at rest and sleep. 
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                    VISUAL ANALOG SCALE 
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FINAL OUTCOME SCORING SYSTEM: 
Excellent: No pain, full movement and activity. 
Good: Occasional pain, full movement and activity. 
Acceptable: Some discomfort after prolonged activity. 
Poor: Pain limiting activity. 
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PATIENTS AND METHODS: 
         This was a prospective study of 50 cases of clinically diagnosed chronic 
plantar fasciitis treated with single dose intra lesional injection of autologous 
blood and steroid (25 cases each) during the period of June-Oct 2011 in 
Coimbatore medical college hospital, Coimbatore. 
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INCLUSION CRITERIA: 
1. Unilateral heel pain > 6 weeks, 
2. Has taken conservative treatment with oral analgesics, foot wear 
modification and physiotherapy modalities for > 4 weeks, with no 
improvement, 
3. Not undergone previous local injections in the heel, 
4. Accepting for further treatment after the study period if pain persists, 
5. Willing for follow-up, 
6. Normotensive, Normoglycaemic patients. 
EXCLUSION CRITERIA: 
1. Bilateral heel pain, 
2. Has undergone previous local injections, 
3. Not willing for follow-up, 
4. Patients with other medical illnesses. 
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PATIENTS: 
Between the above mentioned period, 50 cases of unilateral plantar fasciitis 
who met the above criteria entered the study. 
There were 13 males and 37 females with a mean age of 43.06 years. Range 
was age 23-69 years. 
SEX DISTRIBUTION
Male
Female
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                                   SIDE DISTRIBUTION  
Left:35 
Right:15 
 
SIDE
Left
Right
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                                      AGE DISTRIBUTION 
 
0
5
10
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20
25
Age in yrs
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31‐40
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51‐60
> 60
 
 
 
 
 
 
 
43 
 
The mean duration was 6.26 months. 
The average pre-injection scores were: 
1. Blood injection group: 
VAS: 6.28 
Nirschl: 5.40 
2. Steroid injection group: 
VAS: 5.96 
Nirschl: 5.28 
                                       PRE-INJECTION SCORES 
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INJECTION PROTOCOL: 
1. Patients who met our inclusion criteria were randomly allocated to either of 
the two groups. 
2. Consent was obtained after explaining the study, benefits and complications 
of the procedure and regarding the need for regular follow-up. 
3. X-ray ankle-lateral view was taken for all cases before injection to document 
the presence/absence of heel spur. 
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INJECTION TECHNIQUE: 
1. In case of autologous blood injection, 2 ml of the venous blood was drawn 
from the patient him/ herself and mixed with 1 ml of 2% lignocaine. 
2. In case of steroid, 2 ml of Betamethasone sodium phosphate amounting to 8 
mg was mixed with 1 ml of 2% lignocaine. 
3. Sterile aseptic precautions were followed. 
4. The site of maximum tenderness in the heel was located by careful palpation. 
5. The injection was made through the medial/lateral aspect of the foot. 
6. If the injection is made through the plantar aspect, care was taken not to 
inject it superficially to avoid the risk of fat pad necrosis. 
7. After the injection, patient was allowed to follow our post-injection protocol. 
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POST-INJECTION PROTOCOL: 
1. Ice therapy, 
2. Compression bandage, 
3. Advised not to take NSAID’S for at least 4 weeks post-injection unless pain 
persisted/increased, 
4. No activity restrictions. 
 
 
 
 
 
 
 
 
 
 
47 
 
FOLLOW-UP: 
-          All the patients were followed up at 2, 4 and 12 weeks post-injection. 
-         A total of 7 patients did not return for the final follow-up at 12 weeks 
which included 4 in the steroid group and 3 in the autologous blood group.  
-         At follow up, pain was assessed using the visual analog scale and Nirschl 
stages and compared with their respective pre-injection levels. 
-       Final Outcome was measured based on the pain and activity levels and 
graded into 4 categories.     
-         Patients were also observed for complications if any at the injection site. 
-         Radiographs were analyzed for the presence of heel spur. 
 
COMPLICATIONS: 
1. In steroid group, 1 patient had paraesthesia at the injection site at 2 weeks 
post-injection, but it disappeared at 4 weeks with observation alone. 
2. No case of infection/ cellulitis, plantar fascial rupture, heel pad necrosis was 
observed. 
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DATA ANALYSIS: 
POST-INJECTION SCORES: 
The average post-injection scores at 2 weeks were: 
1. Blood injection group: 
VAS: 4.04 
Nirschl: 3.44 
2. Steroid injection group: 
VAS: 2.32 
Nirschl: 2.16                  POST INJECTION SCORES (2 wks) 
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The average post-injection scores at 4 weeks were: 
1. Blood injection group: 
VAS: 4.56 
Nirschl: 3.72 
2. Steroid injection group: 
VAS: 2.40 
Nirschl: 2.20 
                                 POST INJECTION SCORES (4 wks) 
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
4wks post‐inj B 4wks post‐inj S
VAS
Nirschl
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The average post-injection scores at 12 weeks were: 
1. Blood injection group: 
VAS: 4.22 
Nirschl: 3.36 
2. Steroid injection group: 
VAS: 3.14 
Nirschl: 2.71 
                                POST INJECTION SCORES (12 wks) 
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
12wks post‐inj B 12wks post‐inj S
VAS
Nirschl
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ANALYSIS OF HEEL SPURS: 
Present:27pts(54%) 
Absent:23pts(46%)
Heel spur
Present
Absent
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RESULTS: 
 The average VAS and Nirschl scores in both the groups pre-injection, 2,4 and 
12 weeks post-injection are shown in the below tables.              
                            AUTOLOGOUS BLOOD GROUP 
Pre-injection Post-injection(2 
wks) 
Post-injection(4 
wks) 
Post-
injection(12 
wks) 
VAS Nirschl VAS Nirschl VAS Nirschl VAS Nirschl 
6.28 5.40 4.04 3.44 4.56 3.72 4.22 3.36 
    
                                  STEROID GROUP  
Pre-injection Post-injection(2 
wks) 
Post-injection(4 
wks) 
Post-
injection(12 
wks) 
VAS Nirschl VAS Nirschl VAS Nirschl VAS Nirschl 
5.96 5.28 2.32 2.16 2.40 2.20 3.14 2.71 
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The effects of our injection as observed with the VAS and Nirschl scores in 
both the groups is depicted in a graph given below: 
                                  AUTOLOGOUS BLOOD GROUP 
0
1
2
3
4
5
6
7
Pre‐inj Post‐inj 2 wks Post‐inj 4 wks Post‐inj 12 wks
VAS
Nirschl
 
From the above curve it is clear that the autologous blood group followed a 
gentle curve during the 2 weeks after injection compared to that of the steroid 
curve. At the end of 12 weeks, the effect is still sustained shown by its down 
coming curve pattern. 
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                                           STEROID GROUP 
0
1
2
3
4
5
6
7
Pre‐inj Post‐inj 2 wks Post‐inj 4 wks Post‐inj 12 wks
VAS
Nirschl
 
From the above curve it is clear that the steroid group had a steep curve during 
the 2 weeks after injection compared to that of the autologous blood group 
curve. At the end of 12 weeks, the effect has weaned off shown by its up going 
curve pattern. 
To conclude, the VAS score in the autologous blood group decreased by 2.06    
and the Nirschl score decreased by 2.04   in the 12th week compared to pre-
injection scores. 
Whereas, the VAS score in the steroid group decreased by 2.82 and the Nirschl 
score decreased by 2.57 in the 12th week compared to pre-injection scores. 
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According to the final outcome assessment scoring, the results at post-injection 
12 weeks were as follows: 
AUTOLOGOUS BLOOD GROUP: 
Grade-1(Excellent): 0 
Grade-2(Good): 4 
Grade-3(Acceptable): 18 
Grade-4(poor):0 
Lost follow-up: 3 
 
Final outcome‐Autologous blood group
Excellent
Good
Acceptable
Poor
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STEROID GROUP: 
Grade-1(Excellent): 2 
Grade-2(Good): 8 
Grade-3(Acceptable): 10 
Grade-4(Poor): 1 
Lost follow-up: 4 
Final outcome‐Steroid group
Excellent
Good
Acceptable
Poor
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FINAL OUTCOME WITH RELEVANCE TO HEELSPUR: 
GROUP WITH HEELSPUR: 
Excellent: 2(9.09%) 
Good: 5(22.72%) 
Acceptable: 14(63.63%) 
Poor: 1(4.54%) 
Group with heel spur:Outcome
Excellent
Good
Acceptable
Poor
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GROUP WITHOUT HEELSPUR: 
Good: 7(33.33%) 
Acceptable: 14(66.66%) 
Excellent & Poor: 0 
Group without heel spur:0utcome
Excellent
Good
Acceptable
Poor
 
The final outcome in patients without heel spur was only marginally better than 
in those with heel spur. In the group with heel spur 22.72% had good outcome 
and 63.63% had acceptable outcome. In the group without heel spur 33.33% 
had good outcome and 66.66% had acceptable outcome. There were also 2 
patients with excellent outcome in the group with heel spur whereas there were 
none with excellent outcome in the group without spur. Hence, the final 
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outcomes in patients with heel spur were nearly comparable to that in patients 
without heel spur. 
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DISCUSSION: 
        Plantar fasciitis literally means inflammation of the plantar fascia at the 
site of its attachment to the calcaneum. But recent studies indicate that it is a 
condition of degeneration of the plantar fascia rather than true 
inflammation.Dr.Barrett in 2004 suggested that it is really a degeneration of the 
plantar fascia and called it better as plantar fasciosis. It was also supported by 
the findings of pathologists that only very few inflammatory cells were found 
in specimens received from cases of chronic plantar fasciitis34. The pathology 
passes through a cascade of events including inflammation and degeneration3. 
True inflammation is found only in acute cases and in chronic stages, 
inflammation and degeneration exists together with degeneration dominating 
the other.  This is alike other chronic tendinopathies wherein the features of 
loss of collagen continuity, increase in ground substance, vascularity and 
fibroblasts predominate the lesion4. Several treatment methods exist for chronic 
plantar fasciitis which are broadly classified into conservative and invasive. 
Initially treatment is begun with a combination of conservative methods 
including rest, ice pack application, NSAID’S, footwear modifications 
including arch supports7, 10, and 11. Usually multiple sessions of the modalities 
like ultrasound waves, electrical stimulation, phonophoresis may be required 
before resolution of the condition can occur.  When it is not responsive to the 
above conservative treatment options, local intra-lesional injections or surgical 
plantar fascial release can be considered. Local intra-lesional injections of 
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corticosteroids, botulinum toxin, autologous blood and platelet rich plasma can 
be tried. Several studies indicate the advantage/disadvantage of one treatment 
option over the other18, 19, and 20. 
Autologous blood injection for treatment of chronic plantar fasciitis exists in 
the medical literature only for the past 6 yrs. Edwards and Calandruccio tried 
intra-lesional autologous blood injections for tennis elbow and obtained 
complete pain relief with 1 or 2 injections in all his patients29. It was Dr.Barrett 
who initially tried autologous blood injections for plantar fasciitis with good 
results30. Based on the fact that the pathology in chronic tendinopathies is 
similar, this treatment was extended to chronic plantar fasciitis. 
Recently, Martin et al studied the effect of intra-lesional autologous blood 
injections in chronic plantar fasciitis in over 200 patients and reported good 
results nearing 80%. 
In our study, in the autologous blood group, 18% had good and 82% had 
acceptable outcomes. 
Kane et al conducted a study of intra-lesional corticosteroid injections in 
chronic plantar fasciitis and found 70% better results. 
Furey et al also reported similar results. 
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In our study, in the steroid group, 38% had good, 48% had acceptable and 10% 
had excellent outcomes. 
Lee TG and Ahmad TS conducted a comparative study between autologous 
blood and corticosteroid injection in chronic plantar fasciitis and reported that 
autologous blood was found to be effective in lowering the pain associated with 
the condition, but corticosteroids were much better in the speed and the overall 
outcome of recovery19. 
From the results extrapolated in the graph as discussed before, the autologous 
blood group had a descending/down coming curve pattern at the end of 3 
months, whereas the steroid group had an ascending/up going curve pattern. 
This is due related to a late and sustained beneficial effect of autologous blood. 
Steroid injections provide faster and better relief of pain compared to 
autologous blood, but the beneficial effect is only short lived.  
        Heel spurs may be present in patients with chronic plantar fasciitis.15% of 
the general population have heel spurs5, whereas only 5% of people with heel 
spurs are symptomatic, with the rest 95% being without any symptoms relating 
to the foot. In our study, 54% of patients had heel spurs. In the group with heel 
spur 22.72% had good outcome and 63.63% had acceptable outcome. In the 
group without heel spur 33.33% had good outcome and 66.66% had acceptable 
outcome. There were also 2 patients with excellent outcome in the group with 
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heel spur. Hence, the final outcomes in patients with heel spur were nearly 
comparable to that in patients without heel spur. 
 
In our study, 1 patient in the steroid group had poor outcome and was advised 
another intra-lesional injection of the same substance. 
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CONCLUSION: 
We conclude that in chronic plantar fasciitis: 
1. Local intra-lesional steroid injection gives better pain relief and faster return 
to activities of daily living compared to autologous blood injections. 
2. Autologous blood injections also provide pain relief, although not 
comparable to steroids in the speed of recovery, but produces sustained effects 
and are easily available with no potential risk. 
3. Heel spurs are present in 54 % of patients with chronic plantar fasciitis, 
compared to its 10% presence in general population. 
4. The final outcome in patients with heel spurs was nearly comparable to those 
without heel spurs. 
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L-left           R-right     M-male     F-female      B-blood      S-steroid     VAS-visual analog scale               +: present        
 
P-poor                                      G-good                                 A-acceptable                   E-excellent                - : absent 
 
LF-lost follow-up 
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